BRPI1003988A2 - Método para uso de 4-aminopiridina ao longo de períodos crônicos, e, método para tratamento durável de paciente com esclerose múltipla - Google Patents
Método para uso de 4-aminopiridina ao longo de períodos crônicos, e, método para tratamento durável de paciente com esclerose múltiplaInfo
- Publication number
- BRPI1003988A2 BRPI1003988A2 BRPI1003988-0A BRPI1003988A BRPI1003988A2 BR PI1003988 A2 BRPI1003988 A2 BR PI1003988A2 BR PI1003988 A BRPI1003988 A BR PI1003988A BR PI1003988 A2 BRPI1003988 A2 BR PI1003988A2
- Authority
- BR
- Brazil
- Prior art keywords
- multiple sclerosis
- sclerosis patient
- durable treatment
- over chronic
- aminopyridine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24010009P | 2009-09-04 | 2009-09-04 | |
PCT/US2010/047932 WO2011029082A1 (en) | 2009-09-04 | 2010-09-06 | Durable treatment with 4-aminopyridine in patients with demyelination |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1003988A2 true BRPI1003988A2 (pt) | 2015-08-25 |
Family
ID=43649681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1003988-0A BRPI1003988A2 (pt) | 2009-09-04 | 2010-09-06 | Método para uso de 4-aminopiridina ao longo de períodos crônicos, e, método para tratamento durável de paciente com esclerose múltipla |
Country Status (11)
Country | Link |
---|---|
US (8) | US20130267566A1 (pt) |
EP (2) | EP3210606A1 (pt) |
KR (2) | KR20170120708A (pt) |
CN (1) | CN102143686A (pt) |
AR (1) | AR078323A1 (pt) |
BR (1) | BRPI1003988A2 (pt) |
IL (1) | IL214560A0 (pt) |
MY (1) | MY174829A (pt) |
TW (1) | TW201125562A (pt) |
UY (1) | UY32879A (pt) |
WO (1) | WO2011029082A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8007826B2 (en) | 2003-12-11 | 2011-08-30 | Acorda Therapeutics, Inc. | Sustained release aminopyridine composition |
US8354437B2 (en) | 2004-04-09 | 2013-01-15 | Acorda Therapeutics, Inc. | Method of using sustained release aminopyridine compositions |
US9617215B2 (en) | 2012-05-17 | 2017-04-11 | The University Of Chicago | Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging |
CA2911307C (en) * | 2012-05-17 | 2021-05-25 | The University Of Chicago | Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging |
RU2686116C1 (ru) * | 2018-06-27 | 2019-04-24 | Общество С Ограниченной Ответственностью "Инновационные Фармакологические Разработки" (Ооо "Ифар") | Способ количественного определения 4-амино-1-(3-нитро-2-оксо-1-фенил-1,2-дигидро-1,6-нафтиридин-5-ил)пиридиний хлорида в биологических средах |
WO2021201966A1 (en) | 2020-04-02 | 2021-10-07 | Massachusetts Institute Of Technology | A chip-scale optical coherence tomography engine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1082804A (en) | 1912-11-19 | 1913-12-30 | Gerald G Griffin | Confetti-machine. |
US8007826B2 (en) * | 2003-12-11 | 2011-08-30 | Acorda Therapeutics, Inc. | Sustained release aminopyridine composition |
US8354437B2 (en) * | 2004-04-09 | 2013-01-15 | Acorda Therapeutics, Inc. | Method of using sustained release aminopyridine compositions |
US7884079B2 (en) * | 2004-12-27 | 2011-02-08 | Miller Landon C G | 4-aminopyridine and a pharmaceutical composition for treatment of neuronal disorders |
MX2011008485A (es) * | 2009-02-11 | 2011-11-04 | Acorda Therapeutics Inc | Composiciones y metodos para terapia prolongada con aminopiridinas. |
-
2010
- 2010-09-03 AR ARP100103241A patent/AR078323A1/es unknown
- 2010-09-03 TW TW099130003A patent/TW201125562A/zh unknown
- 2010-09-06 US US13/394,044 patent/US20130267566A1/en not_active Abandoned
- 2010-09-06 EP EP17152965.4A patent/EP3210606A1/en not_active Withdrawn
- 2010-09-06 MY MYPI2011003986A patent/MY174829A/en unknown
- 2010-09-06 KR KR1020177029828A patent/KR20170120708A/ko not_active Application Discontinuation
- 2010-09-06 UY UY0001032879A patent/UY32879A/es not_active Application Discontinuation
- 2010-09-06 BR BRPI1003988-0A patent/BRPI1003988A2/pt not_active IP Right Cessation
- 2010-09-06 KR KR1020127008634A patent/KR20120050512A/ko active Application Filing
- 2010-09-06 WO PCT/US2010/047932 patent/WO2011029082A1/en active Application Filing
- 2010-09-06 EP EP10814616A patent/EP2473039A4/en not_active Ceased
- 2010-09-06 CN CN2010800023728A patent/CN102143686A/zh active Pending
-
2011
- 2011-08-09 IL IL214560A patent/IL214560A0/en unknown
-
2014
- 2014-03-21 US US14/222,535 patent/US20140206728A1/en not_active Abandoned
-
2016
- 2016-03-08 US US15/064,574 patent/US20160184286A1/en not_active Abandoned
- 2016-10-21 US US15/331,713 patent/US20170035742A1/en not_active Abandoned
-
2017
- 2017-06-02 US US15/612,925 patent/US20170266171A1/en not_active Abandoned
-
2018
- 2018-09-06 US US16/124,045 patent/US20190000820A1/en not_active Abandoned
-
2019
- 2019-04-24 US US16/393,586 patent/US20190247378A1/en not_active Abandoned
- 2019-12-06 US US16/706,573 patent/US20200113883A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR078323A1 (es) | 2011-11-02 |
UY32879A (es) | 2011-03-31 |
US20190247378A1 (en) | 2019-08-15 |
KR20120050512A (ko) | 2012-05-18 |
MY174829A (en) | 2020-05-18 |
US20140206728A1 (en) | 2014-07-24 |
US20170266171A1 (en) | 2017-09-21 |
IL214560A0 (en) | 2011-09-27 |
CN102143686A (zh) | 2011-08-03 |
US20170035742A1 (en) | 2017-02-09 |
KR20170120708A (ko) | 2017-10-31 |
TW201125562A (en) | 2011-08-01 |
EP3210606A1 (en) | 2017-08-30 |
US20130267566A1 (en) | 2013-10-10 |
EP2473039A1 (en) | 2012-07-11 |
EP2473039A4 (en) | 2013-01-09 |
WO2011029082A8 (en) | 2011-05-12 |
WO2011029082A1 (en) | 2011-03-10 |
US20160184286A1 (en) | 2016-06-30 |
US20200113883A1 (en) | 2020-04-16 |
US20190000820A1 (en) | 2019-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
CO6791606A2 (es) | Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas | |
BRPI0911923A2 (pt) | dispositivos filamentosos para o tratamento de defeitos vasculares | |
BR112012022878A2 (pt) | composto, composição farmacêutica, uso do compostos e método de tratamento | |
BR112012000568A2 (pt) | tratamento da esclerose múltipla com laquinimod | |
BRPI0914034A2 (pt) | dispositivo para limpeza de piso e método de limpeza de um piso | |
BR112014002621A2 (pt) | anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento | |
BR112013009708A2 (pt) | aparelhos, métodos e composições para tratamento endodôntico | |
HK1202415A1 (en) | Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre | |
BRPI0911612A2 (pt) | composições e métodos para o tratamento da esclerose múltipla. | |
EP2746835A4 (en) | MEDICAL TREATMENT DEVICE, COATING SOLUTION COMPOSITION AND METHOD OF MANUFACTURING THE MEDICAL TREATMENT DEVICE | |
BR112014010179A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição | |
CO6791619A2 (es) | Composición de limpieza de superficies duras | |
BRPI0922871A2 (pt) | metodos para o tratamento da esclerose múltipla usando pirazinoindóis tetracíclicos | |
EP2464652A4 (en) | HAFNIUM AND ZIRCONIUM-CONTAINING PRECEDENTS AND METHOD OF USE THEREOF | |
BR112014013614A2 (pt) | composição antimicrobiana, método para desinfetar uma superfície e uso de uma composição | |
BRPI1007779A2 (pt) | perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina | |
BRPI0912687A2 (pt) | uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia | |
BRPI1003988A2 (pt) | Método para uso de 4-aminopiridina ao longo de períodos crônicos, e, método para tratamento durável de paciente com esclerose múltipla | |
BRPI0906606A2 (pt) | Tratamento terapêutico para condições do pulmão. | |
BR112014013601A2 (pt) | composição antimicrobiana sólida, método para desinfetar uma superfície e uso de uma composição | |
BR112015012443A2 (pt) | composição de limpeza, método de limpeza do corpo humano, uso da composição e método para prover limpeza | |
BR112014013613A2 (pt) | composição antimicrobiana, método de desinfecção de uma superfície e uso de uma composição | |
BR112014013609A2 (pt) | composição antimicrobiana sólida, método da desinfecção de uma superfície e utilização de uma composição | |
BR112013012175A2 (pt) | combinação, coadministração, uso e método |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 3A, 4A E 5A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |